Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.

Grant Approval Process

Grant Approval Process

The Cure Starts Now has funded $30,229,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 199 grants at over 100 hospitals in 29 countries.






Oncoceutics ONC201 - $100,000

Amount
$100,000.00 USD
Date
December 2019

Expansion of the ONC201 Compassionate Use.

Grant Information
Learn More

University of Sydney - $100,000 USD / $146,520 AUD (Approx)

Amount
$100,000.00 USD
Date
November 2019

Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.

Grant Information

University of Michigan Hospitals - $157,856

Amount
$157,856.00 USD
Date
November 2019

Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG

Grant Information

Dayton Children's Hospital - $69,600

Amount
$69,600.00 USD
Date
November 2019

Responses of distinct cell populations to PDGFRA inhibitors in diffuse intrinsic pontine glioma.

Grant Information

Institute of Cancer Research - $121,863

Amount
$121,863.00 USD
Date
November 2019

Targeting Top3A-Amplified DIPG cells by Sirtuin inhibition.

Grant Information

Bambino Gesu Children's Hospital - $49,803

Amount
$49,803.00 USD
Date
August 2019

Using imaging mass cytometry to identify next generation imaging biomarkers in PHGG and DIPG.

Grant Information

Telethon Kids Institute - $49,512 USD / $69,822 AUD (Approx)

Amount
$49,512.00 USD
Date
August 2019

Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.

Grant Information

Oncoceutics ONC201 - Phase II - $83,333

Amount
$83,333.00 USD
Date
May 2019

Expansion of the ONC201 Compassionate Use.

Grant Information
Learn More

Funding of PBTCF 2019: PBTC-058 - $25,000

Amount
$25,000.00 USD
Date
January 2019

PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Grant Information

Sydney Children’s Hospital - $175,089 USD / $242,388 AUD (Approx)

Amount
$175,089.00 USD
Date
November 2018

Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma

Grant Information

Cincinnati Children's Hospital - $540,742

Amount
$540,742.00 USD
Date
November 2018

Expansion of the International DIPG Registry.

Grant Information

Bambino Gesú Children's Hospital - $99,382

Amount
$99,382.00 USD
Date
November 2018

Investigating the Role of DIPG-Derived Exosomes in Tumor Growth and Invasion.

Grant Information

Ann and Robert H. Lurie Children's Hospital of Chicago - $35,000

Amount
$35,000.00 USD
Date
November 2018

Credentialing an Improved DIPG Mouse Model.

Grant Information

Oncoceutics ONC201 - $83,333

Amount
$83,333.00 USD
Date
October 2018

Expansion of the ONC201 Compassionate Use.

Grant Information
Learn More

The Institute of Cancer Research - $100,000

Amount
$100,000.00 USD
Date
October 2018

Short-pulse Ultrasound Delivery of Panobinostat for the Treatment of Diffuse Intrinsic Gliomas in Children

Grant Information